Outcomes & Survival Rates
Penn Medicine is the largest lung transplant program in the region. Since the program's beginning in 1991, more than 825 lung transplants have been performed and the lives of many patients have been drastically improved.
The Scientific Registry of Transplant Recipients (SRTR) is a national database of statistics related to solid organ transplantation – kidney, liver, pancreas, intestine, heart, and lung. Information in the registry is collected by the Organ Procurement and Transplantation Network (OPTN) from every transplant center and organ procurement organization (OPO) in the country.
The SRTR provides useful information about transplant outcomes and transplant programs. While much of the SRTR data is used for statistical research that helps shape organ allocation policy and health care practices, the SRTR also reports statistics for patients.
These reports include outcomes concerning patients on the waiting list and those who receive transplants. Patients and families can also learn how these statistics differ from one transplant program to the next.
The following table highlights recently published "Graft Survival" outcomes at one–month and three–year timeframes for the lung transplant program at Penn.
"Graft Survival" is the percentage of transplanted organs that are still working after transplant.
The "National Average" provides the average graft survival for all lung programs in the country.
Graft Survival Rates (Lung) National Average vs. Penn Medicine
|National Average||Penn Medicine|
- National Average
- Penn Medicine
For more information please visit the Scientific Registry of Transplant Recipients (SRTR) website.
*Data source: Scientific Registry of Transplant Recipients, For Patients Transplanted between 01/01/2009 and 06/30/2011 for the 1 Month and 1 Year Models; between 07/01/2006 and 12/31/2008 for the 3 Year Model. SRTR release July 2012.